EUVIMEDEUVIMED entdecken
Crossref

Advancing antimalarial drug discovery: ensemble machine learning models for predicting PfPK6 inhibitor activity

Maryam Gholami, Mohammad Asadollahi-Baboli

Molecular Diversity · 2025-08 · 29 (4) · 3575-3586

DOI: 10.1007/s11030-025-11203-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Diversity, online erschienen am 22.04.2025. Verfasst von Maryam Gholami und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science, Babol Noshirvani University of Technology, Babol, 47148-71167, Mazandaran, Iran. Hauptthemen laut MEDLINE: Antimalarials, Machine Learning, Plasmodium falciparum, Drug Discovery. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malaria is a significant global health challenge, causing high morbidity and mortality. The rise of drug resistance highlights the urgent need for new antimalarial agents. This study focuses on predictive modeling of 104 Plasmodium falciparum protein kinase 6 (PfPK6) inhibitors, employing a range of machine learning techniques to develop ensemble regression and classification models. Molecular descriptors were refined using classification and regression trees (CART) to identify the most relevant features. Six machine learning algorithms (Random Forest (RF), Relevance Vector Machine (RVM), Support Vector Machine (SVM), Cubist, Artificial Neural Networks (ANN), and XGBoost) were utilized to construct regression models. The consensus model demonstrated superior predictive performance, achieving R2Test = 0.94, SETest = 0.20, Q2CV = 0.90, and SECV = 0.25, outperforming individual models. For classification tasks, five algorithms were evaluated and a majority voting approach yielded an accuracy of 91% and a sensitivity of 93%. The robustness of the models was confirmed through applicability domain analysis (96% coverage) and y-randomization tests, ensuring that the predictive outcomes were not due to chance correlations. This study highlights the effectiveness of ensemble machine learning approaches in predictive modeling and provides critical insights for the rational design of novel PfPK6 inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimalarialsMachine LearningPlasmodium falciparumDrug DiscoveryProtein Kinase InhibitorsProtozoan ProteinsNeural Networks, ComputerAlgorithmsSupport Vector Machine

Stichwörter der Autor:innen

Classification and regression trees (CART)Ensemble machine learning techniquesMalaria treatmentPlasmodium falciparum protein kinase 6 (PfPK6)Quantitative structure–activity relationship (QSAR)

Substanzen

AntimalarialsProtein Kinase InhibitorsProtozoan Proteins

Autor:innen und Institutionen

  • Department of Chemistry, Faculty of Science, Babol Noshirvani University of Technology, Babol, 47148-71167, Mazandaran, Iran.
  • Department of Chemistry, Faculty of Science, Babol Noshirvani University of Technology, Babol, 47148-71167, Mazandaran, Iran. asadollahi@nit.ac.ir.

Zitieren

APA

Gholami, M., & Asadollahi-Baboli, M. (2025). Advancing antimalarial drug discovery: ensemble machine learning models for predicting PfPK6 inhibitor activity. Molecular Diversity, 29(4), 3575-3586. https://doi.org/10.1007/s11030-025-11203-9

Vancouver

Gholami M, Asadollahi-Baboli M. Advancing antimalarial drug discovery: ensemble machine learning models for predicting PfPK6 inhibitor activity. Molecular Diversity. 2025;29(4):3575-3586. doi:10.1007/s11030-025-11203-9

BibTeX
@article{Gholami2025,
  author = {Gholami, Maryam and Asadollahi-Baboli, Mohammad},
  title = {Advancing antimalarial drug discovery: ensemble machine learning models for predicting PfPK6 inhibitor activity},
  journal = {Molecular Diversity},
  year = {2025},
  volume = {29},
  number = {4},
  pages = {3575--3586},
  doi = {10.1007/s11030-025-11203-9}
}
Kostenlos starten →